Loading...
Rheumatoid arthritis patients on persistent moderate disease activity on biologics have adverse 5-year outcome compared to persistent low-remission status and represent a heterogeneous group
BACKGROUND: The long-term outcome of rheumatoid arthritis (RA) patients who in clinical practice exhibit persistent moderate disease activity (pMDA) despite treatment with biologics has not been adequately studied. Herein, we analyzed the 5-year outcome of the pMDA group and assessed for within-grou...
Na minha lista:
| Udgivet i: | Arthritis Res Ther |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7523072/ https://ncbi.nlm.nih.gov/pubmed/32993800 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-020-02313-w |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|